Company Dossier · Health Tech · New York
Cadence
The company that moved chronic care out of the waiting room and into the kitchen.
The company that moved chronic care out of the waiting room and into the kitchen.
It is a Tuesday morning and a 71-year-old in rural Tennessee steps on a scale. She does not think much of it. But three pounds of overnight water weight - the kind that signals a heart slipping toward failure - just traveled, in seconds, from her bathroom to a clinical team a thousand miles away. By lunchtime a nurse has called, adjusted a medication, and kept her out of an emergency room she did not yet know she was heading toward.
That quiet interception is the entire business. Cadence is a clinical technology company that equips patients with chronic conditions - heart failure, hypertension, type 2 diabetes, COPD - with connected devices, then wraps those devices in software and a 24/7 care team that works inside the patient's own health system. Today that machinery runs across more than twenty leading U.S. health systems and tens of thousands of patients in dozens of states.
It is, in other words, a company built around a deeply unglamorous idea: that most medical emergencies announce themselves days in advance, and nobody is listening.
Most chronic-care crises don't arrive. They accumulate. Cadence's whole pitch is that someone should be watching the accumulation. The premise, in one sentence
Chronic disease is the most expensive thing American medicine does, and it is managed in fifteen-minute appointments scheduled months apart. A patient with heart failure might see a cardiologist three or four times a year. The other 361 days, the most sophisticated healthcare system on earth simply hopes for the best.
The result is predictable and grim: people deteriorate quietly at home, then arrive at the emergency department in crisis, where care is most expensive and least effective. Roughly half of chronic-care spending chases problems that early intervention could have prevented. Everyone in the system knows this. The trouble was that nobody owned the gap between appointments.
Rural America has it worst. Fewer specialists, longer drives, thinner margins - exactly the places where a missed warning sign turns into a hospital stay.
"There's a huge opportunity to help millions of people get better treatment." Chris Altchek, Founder & CEO
Chris Altchek did not come from medicine. He came from journalism - the co-founder and CEO of Mic, a millennial news company that burned bright and then, like a lot of digital media, did not. Before that: Goldman Sachs, a Bloomberg mayoral campaign, the White House, a Harvard degree in social studies. An unlikely resume for someone who would spend the back half of the decade thinking about blood pressure cuffs.
The bet he made when founding Cadence in 2020 was contrarian in a specific way. Plenty of startups were shipping health gadgets to consumers and hoping engagement would follow. Altchek bet the opposite: that the device is the easy part, and the hard, valuable, durable thing is the clinical operation behind it - the licensed clinicians, the EHR integration, the relationship with the health system that already has the patient. Hardware is a commodity. Trust is not.
Co-founder Kareem Zaki, a partner at Thrive Capital, helped turn that thesis into a company. Investors agreed fast - perhaps too fast to be polite about it.
Selling a scale is a product. Standing behind the reading 24 hours a day is a company. The distinction Cadence built on
The patient's side of Cadence looks almost boringly simple: a cellular-connected scale, a blood pressure cuff, a glucometer. No app to fumble with, no setup to abandon. You take a reading, it goes up automatically. That simplicity is the point - the people who most need monitoring are often the least interested in fiddling with technology.
The complexity hides behind the curtain. Readings stream into Cadence's platform, where an AI layer the company calls its Proactive Care Engine watches every patient at once, scores risk, and flags the readings that matter to a human care team. Clinicians then do the genuinely medical work: titrating medication toward evidence-based targets, coaching on diet, escalating when something looks wrong. The software finds the needle; the clinician decides what to do with it.
FDA-cleared scale, BP cuff and glucometer that capture vitals daily and sync on their own - no smartphone required.
An AI layer that monitors every patient continuously, surfaces risk, and catches care gaps before they become emergencies.
Licensed clinicians embedded in the health system's workflow and EHR - doing medication titration, coaching and rapid response.
Guideline-directed programs for heart failure, hypertension, type 2 diabetes and COPD, plus post-acute and senior care.
The algorithm finds the needle. A human still decides what it means. Cadence refuses to pretend that's the same job. How the AI and the clinicians divide the work
Health-tech is crowded with companies that promise outcomes and quietly never mention them again. Cadence does something slightly unusual for a private company: it publishes an annual Outcomes Report, a public scorecard inviting anyone to check its math.
The headline numbers are the kind that make a hospital CFO sit up. Among heart-failure patients, Cadence reports a 50% drop in emergency-department visits and a 23% reduction in total cost of care. And in a study with Lifepoint Health, rural patients on the platform reportedly matched or surpassed the outcomes of their urban counterparts - quietly inverting one of the oldest assumptions in American medicine.
Rural patients outperformed urban ones. Geography, it turns out, was never the disease - distance from a clinician was. On the Lifepoint Health results
The partner list reads like a tour of American healthcare: Providence, RUSH, BayCare, Lifepoint, Community Health Systems, Ardent, Memorial Hermann, Hartford HealthCare, Hackensack Meridian, Montefiore Einstein and more.
Cadence states its goal plainly: life-changing care for one million people with chronic conditions by the end of the decade. It is a number specific enough to be embarrassing if missed, which is rather the point.
What makes the mission more than a slogan is the business model underneath it. Because Cadence bills largely through Medicare and value-based arrangements - getting paid when patients stay healthy and out of the hospital - its incentives and its patients' incentives point the same direction. Keeping someone well is not a cost center here. It is the revenue.
A goal you can fail at publicly. That is a more honest mission statement than most companies dare to write. On the one-million target
America is aging, chronic disease is climbing, and the supply of clinicians is not keeping pace. Something has to give, and the realistic answer is not more office visits - it is care that runs continuously in the background, with software handling the watching and humans handling the deciding. That is the world Cadence is building toward, and the AI tools it shipped in 2025 are a bet that the watching can scale faster than the workforce can.
The skeptic's question is fair: plenty of remote-monitoring companies have promised this and faded. Cadence's answer is to keep publishing the numbers and keep signing the health systems that already hold the patients. Less a moonshot, more a slow accumulation - fitting, for a company obsessed with catching things as they accumulate.
Back in rural Tennessee, the 71-year-old finishes her coffee. She never saw the emergency that didn't happen. Her scale did. So did a nurse she has come to know by name. The crisis that used to define chronic care simply never showed up - which, if Cadence is right, is exactly what good medicine is supposed to feel like. Like nothing.
Profile compiled from public sources including Cadence.care, Fierce Healthcare, MobiHealthNews, CB Insights, Gunderson Dettmer, Crunchbase and U.S. House testimony. Outcome and patient figures are company-reported and approximate. Cadence (cadence.care) is unrelated to Cadence Design Systems, the chip-design company.